Online citations, reference lists, and bibliographies.

Impact Of Diabetes Mellitus On Outcomes In Patients With Colon Cancer.

Jeffrey A. Meyerhardt, Paul J. Catalano, Daniel G. Haller, Robert J. Mayer, John S. Macdonald, Al B Benson, Charles S. Fuchs
Published 2003 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE To determine the influence of diabetes mellitus on long-term outcomes and treatment-related toxicity among patients with curatively resected colon cancer. PATIENTS AND METHODS This study was a cohort study within a large, randomized adjuvant chemotherapy trial of 3,759 patients with high-risk stage II and stage III colon cancer treated between 1988 and 1992 throughout the United States. In the cohort, 287 patients were identified as having diabetes mellitus. With a median follow-up of 9.4 years, we analyzed differences in overall survival (OS) and colon cancer recurrence as well as treatment-related toxicity between patients with diabetes and those without diabetes. RESULTS At 5 years, patients with diabetes mellitus, compared with patients without diabetes, experienced a significantly worse disease-free survival (DFS; 48% diabetics v 59% nondiabetics; P <.0001), OS (57% v 66%; P <.0001), and recurrence-free survival (RFS; 56% v 64%, P =.012). Median survival was 6.0 years and 11.3 years for diabetics and nondiabetics, respectively. Compared with patients without a history of diabetes, those with diabetes had a 42% increased risk of death from any cause (P <.0001) and 21% increased risk for recurrence (P =.05) after adjustment for other predictors of colon cancer outcome. Treatment-related toxicities were similar between the two groups, although patients with diabetes experienced an increase in treatment-related diarrhea. CONCLUSION Patients with diabetes mellitus and high-risk stage II and stage III colon cancer experienced a significantly higher rate of overall mortality and cancer recurrence, even after adjustment for other predictors of colon cancer outcome. These results underscore the need for further research to understand the mechanism that underlies this relation.



This paper is referenced by
10.1016/j.clinre.2020.03.022
How does comorbidity affect colon cancer patients' care trajectory? Results from the French EvaCCoR cohort study.
Margot Biscond (2020)
10.1245/s10434-015-5028-8
Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer
Tina Fransgaard (2015)
Der Einfluss von Insulin Glargin auf frühe Stadien der Kolonkarzinogenese in der diabetischen db/db-Maus
Jürgen Staffa (2013)
10.1097/COC.0b013e3181e1d0c0
Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity
Antonella Brunello (2011)
10.1200/JCO.2011.38.0303
Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Ahmed N Dehal (2012)
DYSREGULATION OF O-LINKED β-N-ACETYLGLUCOSAMINE (O-GLCNAC) CYCLING SUPPORTS TUMORIGENICITY OF CANCERS OF THE FEMALE REPRODUCTIVE TRACT
Nicole Morin Jaskiewicz (2018)
10.1200/JCO.2008.17.5935
Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.
Tomasz P. Srokowski (2009)
10.1007/s00592-016-0863-z
Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs
Marjolein M. J. Zanders (2016)
10.1016/j.jpainsymman.2013.08.017
The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy.
Younak Choi (2014)
10.4143/crt.2010.42.2.61
Geriatric oncology: an overview of progresses and challenges.
Martine Extermann (2010)
10.1007/978-3-030-36694-0
Diabetes Complications, Comorbidities and Related Disorders
Enzo Bonora (2020)
The role of physical activity in the molecular regulation of colon cancer risk
Barnabas Shaw (2015)
Chapter 2 How Do We Measure Comorbidity ?
Diana Sarfati (2017)
10.22159/ajpcr.2019.v12i7.33287
AN OVERVIEW OF COLORECTAL CANCER: IMPLICATION OF TWO MEDICINAL PLANTS IN THEIR TREATMENT
Jyothi Basini (2019)
10.1080/10717544.2019.1582729
Poly(3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer
Ionuţ Cristian Radu (2019)
10.1016/j.soard.2013.09.013
The foregut theory as a possible mechanism of action for the remission of type 2 diabetes in low body mass index patients undergoing subtotal gastrectomy for gastric cancer.
Yeongkeun Kwon (2014)
10.1245/s10434-008-9873-6
Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer
Abigail S Caudle (2008)
10.1155/2014/607850
Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors
Robert I Griffiths (2014)
10.1097/DCR.0b013e3182a479f9
Diabetes Mellitus and Colorectal Cancer Prognosis: A Meta-analysis
Katherine T. Mills (2013)
10.1007/978-3-319-44870-1_54-1
Comorbidity in Aging and Cancer
Erika E. Ramsdale (2018)
10.1007/s11255-016-1316-x
Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
Qingling Hua (2016)
10.1002/mc.20771
Diabetes and pancreatic cancer.
Donghui Li (2012)
10.1188/11.CJON.654-658
The complex dual diagnosis of diabetes and cancer.
Crystal Stevens (2011)
10.1007/s00109-017-1558-9
Epidemiology and biology of physical activity and cancer recurrence
Christine M. Friedenreich (2017)
10.1007/s12032-018-1188-2
Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients
Akie Watanabe (2018)
10.3109/9781420017991
Principles and Practice of Surgery for the Colon, Rectum, and Anus, Third Edition
Philip H. Gordon (2007)
10.1016/j.sapharm.2019.11.014
Patient perspectives on primary care and oncology care coordination in the context of multiple chronic conditions: A systematic review.
Natalie S. Hohmann (2019)
10.1371/journal.pone.0149822
The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus
Jia-An Teng (2016)
10.1016/j.clml.2015.03.004
Prognostic effect of comorbidity indices in elderly patients with multiple myeloma.
Jelena S. Bila (2015)
10.4143/crt.2014.46.3.288
Impact of Hyperglycemia on Survival and Infection-Related Adverse Events in Patients with Metastatic Colorectal Cancer Who Were Receiving Palliative Chemotherapy
Yong Joo Hong (2014)
10.4172/2329-9088.1000130
Mid Transverse Colon Cancer and the Related Risk Factors: A Case Report
Amer Hayat Khan (2013)
10.1007/s13668-014-0105-3
The Individual and Combined Effects of Obesity and Type 2 Diabetes on Cancer Predisposition and Survival
R McLean (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar